Literature DB >> 11812523

Inhibition of cocaine self-administration by fluoxetine or D-fenfluramine combined with phentermine.

Andrew C Glatz1, Michelle Ehrlich, Richard S Bae, Michelle J Clarke, Patricia A Quinlan, Emily C Brown, Pedro Rada, Bartley G Hoebel.   

Abstract

Instrumental responding for intravenous cocaine in rats at 85% of free-feeding weight was significantly decreased 50% by D-fenfluramine plus phentermine (D-Fen/Phen, 5 mg/kg of each for 1 day). A similar effect was obtained in normal-weight rats self-administering a cocaine-heroin mixture. Treating normal-weight animals with fluoxetine (5 mg/kg) for 4 days also significantly decreased cocaine self-administration by half, and then adding phentermine caused an additional decrease in cocaine intake. Animals that were well trained to self-administer drug did not self-administer intravenous D-Fen/Phen or Flu/Phen. The present results confirm that serotonergic drugs can decrease cocaine, or cocaine/heroin, self-administration in rats, and that phentermine adds to the effect. Based on related research with the same dose of D-Fen/Phen, it is suggested that effectiveness in reducing cocaine reinforcement is due in part to a satiating effect in which dopamine and acetylcholine are released in the nucleus accumbens.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11812523     DOI: 10.1016/s0091-3057(01)00657-8

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

Review 1.  Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions.

Authors:  Richard B Rothman; Bruce E Blough; Michael H Baumann
Journal:  AAPS J       Date:  2007-01-05       Impact factor: 4.009

Review 2.  Monoamine transporter inhibitors and substrates as treatments for stimulant abuse.

Authors:  Leonard L Howell; S Stevens Negus
Journal:  Adv Pharmacol       Date:  2014

3.  Extending Previous cG×I Findings on 5-HTTLPR's Moderation of Intervention Effects on Adolescent Substance Misuse Initiation.

Authors:  Gabriel L Schlomer; H Harrington Cleveland; Mark E Feinberg; Pedro S A Wolf; Mark T Greenberg; Richard L Spoth; Cleve Redmond; Eric P Tricou; David J Vandenbergh
Journal:  Child Dev       Date:  2016-11-08

Review 4.  Nonhuman primate neuroimaging and cocaine medication development.

Authors:  Leonard L Howell
Journal:  Exp Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.157

Review 5.  Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction.

Authors:  Richard B Rothman; Bruce E Blough; Michael H Baumann
Journal:  Exp Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.157

6.  The effects of concurrent administration of +/-3,4-methylenedioxymethamphetamine and cocaine on conditioned place preference in the adult male rat.

Authors:  Anna J Diller; Angelica Rocha; Aaron L Cardon; Rodrigo Valles; Paul J Wellman; Jack R Nation
Journal:  Pharmacol Biochem Behav       Date:  2007-08-08       Impact factor: 3.533

7.  Effects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys.

Authors:  Matthew L Banks; Paul W Czoty; H Donald Gage; Michael C Bounds; Pradeep K Garg; Sudha Garg; Michael A Nader
Journal:  Neuropsychopharmacology       Date:  2007-04-18       Impact factor: 7.853

Review 8.  Converging vulnerability factors for compulsive food and drug use.

Authors:  Katherine M Serafine; Laura E O'Dell; Eric P Zorrilla
Journal:  Neuropharmacology       Date:  2021-04-20       Impact factor: 5.273

Review 9.  Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.

Authors:  B Jupp; J W Dalley
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

10.  Phentermine, sibutramine and affective disorders.

Authors:  Hoyoung An; Hyunjoo Sohn; Seockhoon Chung
Journal:  Clin Psychopharmacol Neurosci       Date:  2013-04-24       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.